Pharmacological Reports - Home Page
NOTE TO CONTRIBUTORS (PDF format)
EndNote reference style for download
- Scope of the journal. Pharmacological Reports, formerly The Polish Journal
of Pharmacology, publishes papers concerning all aspects of pharmacology, papers dealing
with drug action at the cellular and molecular levels, and papers on the relationship
between molecular structure and biological activity. The language of all publications
is English. Studies on plant extracts are not suitable for Pharmacological Reports.
We only publish reports on compounds with well-defined chemical structures.
- Types of publications. The journal features the publications of the
following categories: regular papers, short communications, and review articles.
Regular papers should present new experimental studies
that constitute a significant contribution to existing knowledge. Theoretical papers
which deal with new ideas and concepts based on earlier findings will also be welcome.
Short communications should present important new findings
in a brief form.
Review articles should cover the most important current
topics or present interpretative and critical accounts. They should not be simple
compilations on subjects of general interest. Review articles are published only by invitation
of the Editor-in-Chief. Authors intending to prepare a review should first contact
- Submission of manuscripts. Manuscripts and figures should be sent by email
to the Editorial Office at email@example.com
(the e-mail server must be able to send and accept attachments up to 15 MB in size).
Submission is free of charge and must be completed online.
The submitted manuscript should be accompanied by a written statement
that the manuscript has not and will not be published in whole or in part in any other
Additionally, it is obligatory that the authors send the names, addresses,
and email addresses of eight to ten potential reviewers. Although the journal does not
guarantee that these reviewers will be invited, the Editors will take these suggestions
into consideration. These recommendations will help the journal to speed up the editorial
Each manuscript will be given a registration number by the Editorial
Office, and this number should be cited in all correspondence and included in all file names.
All submitted papers will be evaluated by independent reviewers,
and are subject to editorial revision. The author(s) will receive the original
manuscript with the comments of the editors and reviewers, on the basis of which the
final version should be prepared. This version must fulfill the requirements listed
in the Note to Contributors. The authors take full responsibility for any errors in the
- Volume of the manuscript. Brevity and clarity of presentation are essential.
Lengthy historical introductions and long speculative discussions are unacceptable.
The maximum length of regular papers is 5,000 words, and 9,000 words
is the maximum for review articles. The length of short communications should not exceed
3,000 words, four illustrations (figures and tables), and 20 references.
- Form of the manuscript. The manuscript should be double-spaced, with
wide margins, on A-4 size paper. All pages, including the title page, must be
numbered. No specific enhancements (underlining, capitalization, wider margins,
different spacing, etc.) should be used in the body of the manuscript.
If necessary, appropriate proofreading marks may be inserted as comments in the
manuscript. Each new paragraph should be marked by indentation. Headings
(e.g., Methods or Results) should be centered. The approximate positions of figures
and tables should be indicated in the margin.
Authors are required to submit an electronic copy of their
paper by e-mail, preferentially in Rich Text Format or Microsoft Word format, with TIFF,
EPS, CDR (ver. 11), Microsoft Excel, Power Point, or SigmaPlot format for graphic
files. Each figure should be submitted as a separate file.
- Language. Researchers who are not native speakers of English and submit
manuscripts to international journals sometimes receive negative comments from
reviewers or editors about the English language and grammar usage in their
manuscripts, and these problems can contribute to a decision to reject a paper.
To help reduce the possibility of such problems, we strongly encourage such authors
either to have the manuscript reviewed for clarity by a native English speaker or
a graduate of English studies or to use one of many English language editing services
(e.g., "American Journal Experts"; see: www.journalexperts.com). Please note that
any language editing is at the authors' own expense. Authors who are not native
English speakers are requested to attach a certificate at the time of submission
confirming that professional language editing has been performed.
- Organization of the manuscript. Each manuscript must be accompanied
by a letter of submission. In this letter authors should declare their individual
contribution to the manuscript and disclose any actual or potential conflict of
interest. If the paper involves work with animals or animal tissues, the letter
should contain a statement declaring that the work was carried out according to
statutory bioethical standards and was approved by a bioethical committee or
an equivalent body.
Regular papers, short communications and review articles
should include the following elements: title page, abstract page, report pages,
references, tables, graphs, figures and legends.
Title page should include:
- The title (not more than 120 characters, including spaces)
- Authors' names listed as follows: first name, middle initial (if any),
- The name(s) and full postal address(es) (street, zip code, city,
and country) of the affiliated institution(s) in which the work was performed
- The name and e-mail address of the corresponding author
- The running head (up to 60 characters, including spaces)
The abstract page should include:
- The body of the abstract (up to 250 words but no longer than 100 words
for a short communication). The abstract should present the aims of the study,
the major findings (with specific data, if possible) and the principal
conclusions. The abstract must be structured into separate sections:
Background outlining the context and purpose of the study; Methods
containing a short description of methodologies used; Results reporting
the main findings; and Conclusions including a brief summary and potential
- A list of four to eight key words
- A list of abbreviations should be provided if more than four abbreviations
are used. A list of abbreviations must be arranged in alphabetical order
The report pages for regular articles should be divided into:
INTRODUCTION (up to 750 words), briefly describing
the background of the investigation and stating the aim of the study.
MATERIALS and METHODS. Animals and chemicals
should be described in the first two paragraphs. The source of chemicals
and drugs should be given unless obviously unnecessary. The basis of dosage
calculation (free form or salt) should be indicated. Sex, strain and
approximate weight of animals should be given (e.g., male Wistar rats
100-230 g) and housing and feeding conditions should be briefly described.
The dosage schedules do not need be mentioned in the Materials
and Methods section if they are easily discernible from graphs or tables.
The route of administration (po, iv, ip, icv), solvent used, etc. should
Newly introduced techniques should be described
in detail to allow experiments to be easily reproduced. Any modifications
to previously described methods should be specified briefly, with proper
references. Techniques that have been previously described should only
be mentioned in brief, with proper references, unless they were published
in sources that are not easily accessible.
RESULTS and their significance should be
presented clearly and concisely, preferably in the form of graphs and
tables that should be self-explanatory. However, if there are only a few
numerical data, it might be both economical and more legible to describe
them in the body text. Authors are requested to report the results only
once (i.e. not to repeat them in figures or in the text if data are already
presented in tables).
DISCUSSION (up to 1500 words) should contain
a critical review of the results of the study in the light of relevant
literature. It should end with brief conclusions.
In short communications, the Results and Discussion
sections may be combined.
ACKNOWLEDGMENTS (including financial support)
are placed at the end of report pages.
REFERENCES should be arranged alphabetically,
numbered consecutively and referred to in the text preferably by the number
only (in square brackets). If a paper by more than two authors is quoted
by authors names, use the name of the first author followed by et al.
and the reference number, e.g., Bunney et al. . References in the list
should include: the consecutive reference number, names and initials of
authors (if there are not more than seven names all should be listed, for
eight or more authors, the first seven names should be listed followed by
et al.), the title of the article, the title of the journal (abbreviated
according to PubMed usage), the year and volume of the publication, and the
first and last page numbers. In the case of a book reference, the title
should be followed by additional information concerning edition (if relevant),
publishing house, place of publication (the first one, if more than one
are given), and year of publication. The page number or numbers may be
indicated. For a chapter in a collective volume, give the title of the
chapter quoted, followed by the book title, surname(s) and initials of
editors, followed by the same information is required as for books and by
inclusive pagination. Use standard American transcription for author names,
book titles, names of towns, etc. if the original reference is written in
a non-Latin alphabet. The title of the paper may be translated into
English, followed by a statement of the language of the original paper.
- Byrtus H, Pawłowski M, Duszyńska B, Wesołowska A,
Chojnacka-Wójcik E, Bojarski AJ: Arylpiperazine derivatives of
3-propyl-beta-tetralonohydantoin as new 5-HT1A and 5-HT2A receptor
ligands. Pol J Pharmacol, 2002, 53, 395-401.
- Lacko A, Włodarska I, Zymlinski R, Mazur G, Wróbel T, Gisterek I:
Cardiac toxicity in cancer therapy (Polish). Pol Merkuriusz Lek,
2002, 13, 79-85.
- Leonard BE: The potential contribution of sigma receptors
to antidepressant actions. In: Antidepressants: New Pharmacological
Strategies. Ed. Skolnick P, Humana Press, Totowa, 1997, 159-172.
- Strachan T., Read AP: Human Molecular Genetics, 2nd edn., BIOS
Scientific Publishers Ltd., Oxford, 1999.
Only printed books, articles and papers accepted
for publication (not merely submitted), and websites may be quoted in
the references list. Private information and unpublished data may be
mentioned only in the text. Avoid citing sources difficult to locate and
of low status (e.g., internal bulletins or abstracts of local meetings).
Reference style can be downloaded here (EndNote format):
TABLES, ILLUSTRATIONS, and GRAPHS. Tables should be
numbered consecutively using Arabic numerals in the order in which they appear
in the text. Each table should be typed on a separate sheet (A-4 size) together
with explanations, that are double-spaced. A title should be placed above the
table. The table should be constructed in such a way as to minimize blank spaces
and should not exceed one page in length.
Illustrations and graphs should be referred to and
numbered consecutively using Arabic numerals in the order in which they appear
in the text. The authors are requested to provide at submission all figures of
sufficient high quality to be assessed in the peer review process, preferably
in TIFF or EPS format. The minimum resolution for illustrations, graphs,
annotated artwork, photographs, and micrographs is 600 dpi.
The following sizes are recommended: figure width should preferably
fit into a single column or double column of the printed journal wherever
possible; text and labeling should be typed in standard fonts using a font
size of 8-10 (a sans serif typeface such as Arial, Helvetica, or Futura is
preferred); and line width should be 0.6 to 1 pt. Color prints are accepted
only when absolutely necessary (e.g., some immunohistochemical images).
The amount of lettering in graphs should be kept to a minimum;
explanations should be given in captions and legends. A list of figure captions
should be typed on a separate page. The figure legends should explain the figures
in sufficient detail to allow readers to understand it without reference to the
text, whenever possible. Legends, captions and labels should be consistent with
terminology and/or nomenclature used in the text.
- Experimental procedures. Authors should adhere very carefully
to the ethical standards for animal experimentation. Appropriate guidelines
for the acquisition and care of animals can be found in the NIH Guide for
the Care and Use of Laboratory Animals (National Institutes of Health
Publications No. 80-23, revised 1978).
The Editors reserve the right to reject papers if there
is any doubt as to whether suitable procedures have been followed.
- Analytical and spectral data. All new compounds described in
the paper must be characterized by elemental analyses that agree with
the calculated values within 0.4%. Elemental analyses should be collected
in a separate table which will not be printed. Elemental analysis for each
new compound should appear in the text as follows: Analysis for
C(11)H(25)N(3)O (215.2): C,H,N. The structure of all new compounds must
be confirmed by modern spectroscopic techniques (e.g., NMR or mass spectra).
The homogeneity of compounds should be checked using a routine chromatographic
- Nomenclature. Standard American nomenclature should be used
throughout the manuscript. General spellings should comply with the current
Merriam-Webster Dictionary. Authors should use systematic names of chemicals
recommended by IUPAC or names similar to those used by Chemical Abstract
Service or The Merck Index. Dorlands Illustrated Medical Dictionary is
authoritative text for medical nomenclature. Drug names should preferably
be those recommended by WHO and only non-proprietary names are acceptable
(if necessary, consult Marlers Pharmacological and Chemical Synonyms).
Proprietary trade names should be used in parentheses in the Methods section,
and the manufacturer should be identified by name and country.
Example: Oxcarbazepine (Trileptal, Novartis Pharma,
- Units and abbreviations. Standard SI units and their
abbreviations should be used. However, the use of legal non-SI units of
length (A), volume (l, ml, ul), time (min, h, s) and temperature (°C)
is encouraged. Doses should be expressed in grams (and derivatives) or
moles (and derivatives) per kilogram of body weight. Concentrations should
be written in grams (or moles) per liter or milliliter, or per gram or
milligram. Notations such as ml/kg, mmol/kg, or mg/ml are preferred to ml x
kg-2, mmol x kg-2, or mg x ml-1.
Doses administered intracranially (e.g., icv, intra-VTA) should
and human doses may be calculated per subject. In addition to standard
abbreviations, the names of drugs, enzymes, reagents, etc. may be
abbreviated, provided that the abbreviation is listed in the abbreviation
list and that, at the first occurrence of the abbreviation (in both the
abstract and the main body of the manuscript), the abbreviation is explained.
Abbreviations should not be used in the title and should not be confusing.
They should be based on American English spelling and preferably consist
of three capital letters. The same abbreviations must be used in the text
and in figures and tables. Use abbreviations only if they provide substantial
- Software. All software employed in molecular modeling, QSAR,
and other studies must be specified by name and source. When
conformational calculations are used, the potential functions or
parametrization of the method should be stated to facilitate reproduction
of the information and results presented in the paper.
- Reprints. The corresponding author, will be provided with a PDF
file of the article via e-mail at no cost. Paper offprints can be ordered
for an extra charge. Please contact the Editorial Office directly after
you obtain the acceptance note.
- Copyright. Papers submitted for publication in the Journal
are published according to the binding copyright law in Poland.
Last updated: Cracow, May, 2012 by W. Zajaczkowski